RNF169 and myeloid sarcoma: The RNA-seq results showed that expression of E3 ubiquitin ligases, RNF7, RNF19A, RNF157, RNF169, RNF213, and RNF214, were significantly different between the CD4+ T cells of the HC and patients with MS (Figure 1A).